MCMedicalCodingSoftware
J3070

J3070: Injection, pentazocine, 30 mg

HCPCSActiveBETOS O1E

J3070 is a HCPCS Level II code for injection, pentazocine, 30 mg. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.

Medicare coverage: Special coverage instructions apply

There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q4-Oct. This states Medicare’s position on the code, not on your particular claim.

Physician fee schedule statusE

Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

Global period: XXX

Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.

Medically Unlikely Edits: units per day

The most units of J3070 Medicare will pay on one date of service. Bill more on a single line and it is denied. The limit is not the same in every setting, so the row that matters is the one matching the claim you are building.

practitioner
3 units
MAI 3: Date of Service Edit: Clinical · Clinical: Data
outpatient
3 units
MAI 3: Date of Service Edit: Clinical · Clinical: Data
DME supplier
0, never payable
MAI 3: Date of Service Edit: Clinical · CMS Policy

The adjudication indicator decides whether exceeding the limit is worth appealing at all: MAI 1 is a line edit you can support with documentation, MAI 3 is a date-of-service edit that is also appealable, and MAI 2 is absolute, no documentation overrides it. CMS MUE 2026Q4.

The CMS record for J3070

Long descriptor
Injection, pentazocine, 30 mg

The official wording. This is what the code means.

Short descriptor
Pentazocine injection

CMS's 28-character form, which is what shows up on a remittance advice.

Added
January 1, 1982

When CMS introduced the code.

BETOS
O1E

Berenson-Eggers Type of Service: CMS's own analytic grouping.

Pricing indicator
51: Other

Drugs.

Codes adjacent to J3070

HCPCS has no hierarchy: related items simply sit next to each other in the numbering. If J3070 is not quite right, the correct code is very often within a few positions of it.

  • J2998Injection, plasminogen, human-tvmh, 1 mg
  • J3000Injection, streptomycin, up to 1 gm
  • J3010Injection, fentanyl citrate, 0.1 mg
  • J3030Injection, sumatriptan succinate, 6 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
  • J3031Injection, fremanezumab-vfrm, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered)
  • J3032Injection, eptinezumab-jjmr, 1 mg
  • J3055Injection, talquetamab-tgvs, 0.25 mg
  • J3060Injection, taliglucerase alfa, 10 units
  • J3090Injection, tedizolid phosphate, 1 mg
  • J3095Injection, telavancin, 10 mg
  • J3101Injection, tenecteplase, 1 mg
  • J3105Injection, terbutaline sulfate, up to 1 mg
  • J3110Injection, teriparatide, 10 mcg
  • J3111Injection, romosozumab-aqqg, 1 mg
  • J3120Injection, testosterone enanthate, up to 100 mgterminated
  • J3121Injection, testosterone enanthate, 1 mg
HCPCS Level II2026Q4-Oct· effective October 1, 2026